491 related articles for article (PubMed ID: 19223157)
1. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
2. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
Fantegrossi WE; Ko MC; Woods JH; Richelson E
Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187
[TBL] [Abstract][Full Text] [Related]
4. NT69L, a novel analgesic, shows synergy with morphine.
Boules M; Shaw A; Liang Y; Barbut D; Richelson E
Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.
Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E
Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217
[TBL] [Abstract][Full Text] [Related]
6. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
Smith KE; Boules M; Williams K; Richelson E
Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive.
Buhler AV; Choi J; Proudfit HK; Gebhart GF
Pain; 2005 Mar; 114(1-2):285-94. PubMed ID: 15733655
[TBL] [Abstract][Full Text] [Related]
9. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.
Pettibone DJ; Hess JF; Hey PJ; Jacobson MA; Leviten M; Lis EV; Mallorga PJ; Pascarella DM; Snyder MA; Williams JB; Zeng Z
J Pharmacol Exp Ther; 2002 Jan; 300(1):305-13. PubMed ID: 11752130
[TBL] [Abstract][Full Text] [Related]
10. Involvement of NTS2 receptors in stress-induced analgesia.
Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
[TBL] [Abstract][Full Text] [Related]
11. Endogenous neurotensin facilitates visceral nociception and is required for stress-induced antinociception in mice and rats.
Gui X; Carraway RE; Dobner PR
Neuroscience; 2004; 126(4):1023-32. PubMed ID: 15207335
[TBL] [Abstract][Full Text] [Related]
12. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
Brun P; Mastrotto C; Beggiao E; Stefani A; Barzon L; Sturniolo GC; Palù G; Castagliuolo I
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G621-9. PubMed ID: 15764810
[TBL] [Abstract][Full Text] [Related]
14. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice.
Kim ER; Leckstrom A; Mizuno TM
Behav Brain Res; 2008 Dec; 194(1):66-71. PubMed ID: 18639588
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice.
Hunter JC; Fontana DJ; Hedley LR; Jasper JR; Lewis R; Link RE; Secchi R; Sutton J; Eglen RM
Br J Pharmacol; 1997 Dec; 122(7):1339-44. PubMed ID: 9421280
[TBL] [Abstract][Full Text] [Related]
17. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P
Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077
[TBL] [Abstract][Full Text] [Related]
20. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.
Smith KE; Boules M; Williams K; Fauq AH; Richelson E
Behav Brain Res; 2011 Oct; 224(2):344-9. PubMed ID: 21718721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
